伝染病薬市場2020：地域の見通し（アメリカ、ヨーロッパ、アジア太平洋、中東、アフリカ）別のサイズ、業界分析レポート、成長の可能性、価格動向、競争力のある市場シェア、市場統計と予測2020-2025 (アップデート版あり)

このレポートには、最新の市場図、統計、データが含まれています

ライセンスを選択

概要
目次

このレポートでは、伝染病の薬を研究します。伝染病は、細菌、ウイルス、真菌、寄生虫などの生物によって引き起こされる障害です。
まとめグローバル伝染病薬市場は、2015年から2019年までのCAGR xx％でxxx百万米ドルと評価されました。その後、2020年にはXXX百万米ドルに達し、2020年から2025年までのCAGRはxx％になります。

世界の伝染病薬市場では、このレポートは特に北アメリカ、南アメリカ、ヨーロッパとアジア太平洋、および中東とアフリカに焦点を当てています。このレポートは、アプリケーション、タイプ、地域、および製造業者に基づいて市場を分類します。

メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Novartis
Gilead
GSK
Janssen Pharmaceutical
Roche
BioCryst Pharmaceuticals
Merck
Boehringer Ingelheim

地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米（米国、カナダ、メキシコ）
ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
アジア太平洋（中国、日本、韓国、インド、東南アジア）
南アメリカ（ブラジル、アルゼンチン、コロンビアなど）
中東およびアフリカ（サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ）

タイプによる市場細分化：
HIV
インフルエンザ
TB
マラリア
肝炎
HPV
アプリケーションによる市場細分化：
病院
診療所
他の
この調査は、次の重要な質問に対する回答を提供します。
• 2020年から2025年の予測期間における伝染病薬市場の推定成長率と市場シェアおよび規模はどのくらいですか？
• 予測期間2020年から2025年の伝染病薬市場の原動力は何ですか？
• 著名なマーケットプレーヤーは誰ですか？彼らは他の競合他社に対してどのように競争力を獲得しましたか？
• 世界中の伝染病薬の業界の進歩に影響を与える市場動向は何ですか？
• 業界の進歩を制限する主な課題と脅威は何ですか？
• 市場は著名な市場プレーヤーにとってどのような機会を持っていますか？
このレポートに関する特別な要件がある場合は、お知らせください。カスタムレポートを提供できます。

注–より正確な市場予測を提供するために、COVID-19の影響を考慮して、すべてのレポートが配信前に更新されます。

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Communicable Diseases Drugs Market Size Growth Rate by Type (2020-2025)
1.3.2 HIV
1.3.3 Influenza
1.3.4 TB
1.3.5 Malaria
1.3.6 Hepatitis
1.3.7 HPV
1.4 Market Segment by Application
1.4.1 Global Communicable Diseases Drugs Market Share by Application (2020-2025)
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Communicable Diseases Drugs Market Size
2.1.1 Global Communicable Diseases Drugs Revenue 2015-2025
2.1.2 Global Communicable Diseases Drugs Sales 2015-2025
2.2 Communicable Diseases Drugs Growth Rate by Regions
2.2.1 Global Communicable Diseases Drugs Sales by Regions 2015-2019
2.2.2 Global Communicable Diseases Drugs Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Communicable Diseases Drugs Sales by Manufacturers
3.1.1 Communicable Diseases Drugs Sales by Manufacturers 2015-2019
3.1.2 Communicable Diseases Drugs Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Communicable Diseases Drugs Revenue by Manufacturers (2015-2019)
3.2.2 Communicable Diseases Drugs Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Communicable Diseases Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Communicable Diseases Drugs Price by Manufacturers
3.4 Key Manufacturers Communicable Diseases Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Communicable Diseases Drugs Market
3.6 Key Manufacturers Communicable Diseases Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 HIV Sales and Revenue (2015-2019)
4.1.2 Influenza Sales and Revenue (2015-2019)
4.1.3 TB Sales and Revenue (2015-2019)
4.1.4 Malaria Sales and Revenue (2015-2019)
4.1.5 Hepatitis Sales and Revenue (2015-2019)
4.1.6 HPV Sales and Revenue (2015-2019)
4.2 Global Communicable Diseases Drugs Sales Market Share by Type
4.3 Global Communicable Diseases Drugs Revenue Market Share by Type
4.4 Communicable Diseases Drugs Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Communicable Diseases Drugs Sales by Application

6 United States
6.1 United States Communicable Diseases Drugs Breakdown Data by Company
6.2 United States Communicable Diseases Drugs Breakdown Data by Type
6.3 United States Communicable Diseases Drugs Breakdown Data by Application

7 European Union
7.1 European Union Communicable Diseases Drugs Breakdown Data by Company
7.2 European Union Communicable Diseases Drugs Breakdown Data by Type
7.3 European Union Communicable Diseases Drugs Breakdown Data by Application

8 China
8.1 China Communicable Diseases Drugs Breakdown Data by Company
8.2 China Communicable Diseases Drugs Breakdown Data by Type
8.3 China Communicable Diseases Drugs Breakdown Data by Application

9 Rest of World
9.1 Rest of World Communicable Diseases Drugs Breakdown Data by Company
9.2 Rest of World Communicable Diseases Drugs Breakdown Data by Type
9.3 Rest of World Communicable Diseases Drugs Breakdown Data by Application
9.4 Rest of World Communicable Diseases Drugs Breakdown Data by Countries
9.4.1 Rest of World Communicable Diseases Drugs Sales by Countries
9.4.2 Rest of World Communicable Diseases Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.1.4 Communicable Diseases Drugs Product Introduction
10.1.5 Novartis Recent Development
10.2 Gilead
10.2.1 Gilead Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.2.4 Communicable Diseases Drugs Product Introduction
10.2.5 Gilead Recent Development
10.3 GSK
10.3.1 GSK Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.3.4 Communicable Diseases Drugs Product Introduction
10.3.5 GSK Recent Development
10.4 Janssen Pharmaceutical
10.4.1 Janssen Pharmaceutical Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.4.4 Communicable Diseases Drugs Product Introduction
10.4.5 Janssen Pharmaceutical Recent Development
10.5 Roche
10.5.1 Roche Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.5.4 Communicable Diseases Drugs Product Introduction
10.5.5 Roche Recent Development
10.6 BioCryst Pharmaceuticals
10.6.1 BioCryst Pharmaceuticals Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.6.4 Communicable Diseases Drugs Product Introduction
10.6.5 BioCryst Pharmaceuticals Recent Development
10.7 Merck
10.7.1 Merck Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.7.4 Communicable Diseases Drugs Product Introduction
10.7.5 Merck Recent Development
10.8 Boehringer Ingelheim
10.8.1 Boehringer Ingelheim Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Communicable Diseases Drugs
10.8.4 Communicable Diseases Drugs Product Introduction
10.8.5 Boehringer Ingelheim Recent Development

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Communicable Diseases Drugs Sales Channels
11.2.2 Communicable Diseases Drugs Distributors
11.3 Communicable Diseases Drugs Customers

12 Market Forecast
12.1 Global Communicable Diseases Drugs Sales and Revenue Forecast 2020-2025
12.2 Global Communicable Diseases Drugs Sales Forecast by Type
12.3 Global Communicable Diseases Drugs Sales Forecast by Application
12.4 Communicable Diseases Drugs Forecast by Regions
12.4.1 Global Communicable Diseases Drugs Sales Forecast by Regions 2020-2025
12.4.2 Global Communicable Diseases Drugs Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer